Aignostics
Series BBerlin, GermanyOct 2024
Aignostics raised €32M in a Series B round in Oct 2024. The company is based in Berlin, Germany. Investors in the round: Athos Capital, Boehringer Ingelheim Venture Fund, Carma Fund and 4 others. Data as of Nov 2026.
Amount raised
€32M
€31,557,453
Native amount
34,000,000 USD
Stage
Series B
series b
Investors
7
Provenance & confidence
High confidenceAmount
34,000,000 USD
ECB-at-date → €32M · rate 1.0774 on 2024-10-29
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedAthos CapitalBoehringer Ingelheim Venture FundCarma FundHigh-Tech Gründerfonds (HTGF)IBB Ventures’ VC Fonds TechnologieMayo ClinicWellington Partners
Date
Oct 2024
Round type
series b
Amount (EUR)
€32M
Other rounds
same companyRelated news
- Aignostics secures €14M to transform pathology with AItechfundingnews.com · 2022-09
- finsmes.com